Keywords: Drug-eluting beads; Microspheres; Transarterial chemoembolization; Hepatocellular carcinoma; Biodegradable; Degradable; Antiangiogenic; Controlled release; Local delivery; Pharmacokinetics; Bevacizumab (PubChem CID: 24801580); Cisplatin (PubChem CID 44120
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Pneumothorax; Antiangiogenic; Solid tumors; Cavitary pulmonary lesions
Keywords: Antiangiogenic; Collagen XVIII; Matrix metalloproteinases; NF-kappa B; VEGF
Keywords: Coumarin analogs; Antitumor; Antiangiogenic; Proapoptotic
Keywords: Prostate; Antiangiogenic; Finasteride; Aging; Hormone receptor
Keywords: antiangiogenic; peripartum cardiomyopathy; preeclampsia; CI; confidence interval; LVEF; left ventricular ejection fraction; PE; pre-eclampsia; PPCM; peripartum cardiomyopathy; sVEGFR1; soluble vascular endothelial growth factor receptor-1;
Keywords: Evaluation of lung cancer treatment; Personalized medicine; Tyrosine kinase inhibitor; Antiangiogenic; Immunotherapy
DMH4, a VEGFR2 inhibitor, effectively suppresses growth and invasion of lung cancer cells
Keywords: DMH4; Lung cancer; Antiangiogenic; Small molecules; VEGF; VEGFR2;
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
Keywords: Brain metastasis; NSCLC; Non-oncogene addicted; Chemotherapy; Antiangiogenic; Immunotherapy;
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results
Keywords: Antiangiogenic; Epidermal growth factor receptor; First-line; Vascular endothelial growth factor receptor; NCT02411448;
A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SO
Keywords: Antiangiogenic; CD105; CD146; CEC; Predictive markers; Cell search;
Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance
Keywords: CZIHGJNXMXKBHW-UHFFFAOYSA-D; Targeting antitumor Pt(IV) prodrug; COX inhibitor; Drug resistance; Antiangiogenic; Biotin;
In vitro antitumor and antiangiogenic effects of Bothropoidin, a metalloproteinase from Bothrops pauloensis snake venom
Keywords: Snake venom metalloproteinase; MDA-MB-231 cells; Antitumor; Antiangiogenic;
Imagerie du suivi post-thérapeutique des traitements personnalisés systémiques du cancer bronchique
Keywords: Ãvaluation du traitement du cancer bronchique; Médecine personnalisée; Inhibiteur de tyrosine kinase; Antiangiogénique; Immunothérapie; Lung cancer treatment evaluation; Personalized medicine; Tyrosine kinase inhibitor; Antiangiogenic; Immunotherapy;
Epithelioid hemangioendothelioma treated with bevacizumab: A case series
Keywords: Antiangiogenic; Bevacizumab; Chemotherapy; Epithelioid hemangioendothelioma; Vascular endothelial growth factor (VEGF);
Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer
Keywords: Synergistic treatment; Co-delivery of siRNA and doxorubicin; Multifunctional nanocomplex; Antiangiogenic; Cytotoxicity
Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment
Keywords: DCE-MRI; Gd-complexes; Pharmacokinetic modeling; Clustering; Antiangiogenic; Tumor heterogeneity;
Bevacizumab as First-Line Therapy for Patients With Brain Metastases From Renal Carcinoma: A Case Series
Keywords: Antiangiogenic; Cerebral; Kidney; Target therapy; VEGF;
Antiangiogenic activity of neutral lipids, glycolipids, and phospholipids fractions of Pinus halepensis Mill. seeds
Keywords: Pinus halepensis Mill.; Neutral lipids; Glycolipids; Phospholipids; Cells toxicity; Antiangiogenic
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma
Keywords: Angiogenesis; Antiangiogenic; VEGF; Clear cell; Resistant;
Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: A clinician's perspective
Keywords: Metastatic colorectal cancer; Bevacizumab; Ziv-aflibercept; Regorafenib; Angiogenesis; Ramucirumab; Antiangiogenic;
Original studyPhase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer
Keywords: Antiangiogenic; Anti-VEGF; Chemotherapy; HER2; Taxane;
Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy
Keywords: Resveratrol; Nanoemulsion; Solubility; Cytotoxicity; Antiangiogenic;
Activity of sunitinib in extraskeletal myxoid chondrosarcoma
Keywords: Sarcoma; Extraskeletal myxoid chondrosarcoma; Chondrosarcoma; Sunitinib; Antiangiogenic; Chemotherapy;
Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols
Keywords: Amidopyridinol; Angiogenesis; Antiangiogenic; Antitumor; Chick chorioallantoic membrane assay;
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial
Keywords: Phase I; Dovitinib; Antiangiogenic; Clinical trial; RET genetic variant; Sensitizing genetic variant;
Screening of antiangiogenic potential of twenty two marine invertebrate extracts of phylum Mollusca from South East Coast of India
Keywords: Marine invertebrate; Mollusca; Antiangiogenic; CAM; Cautery; Retinopathy
6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity
Keywords: Aminopyridinol; Angiogenesis; Antiangiogenic; Antitumor; Chick chorioallantoic membrane assay
The antiangiogenic activity of Kushecarpin D, a novel flavonoid isolated from Sophora flavescens Ait
Keywords: Sophora flavescens Ait; Flavonoid; Kushecarpin D; Antiangiogenic; Cell cycle arrest; Reactive oxygen species;
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo
Keywords: Aminopeptidase N; Angiogenesis; Cancer; Prodrug; Antiangiogenic;
Dendronized heparinâdoxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy
Keywords: Nanoparticle; Dendrimer; Heparin; Antiangiogenic; Antitumor; Toxicity;
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Keywords: Itraconazole; Antiangiogenic; Lung cancer
Évaluation de la prise en charge du cancer du rein métastatique à l’ère des thérapies ciblées. Étude clinique rétrospective sur six ans
Keywords: Cancer; Rein; Métastatique; Anti-angiogéniques; Thérapies cibléesCancer; Kidney; Metastasis; Antiangiogenic; Targered therapies
Destruxins: Fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities
Keywords: Antiangiogenic; Anticancer; Cyclodepsipeptides; Cytostatic; Destruxins
Reappraisal of the Role of Bevacizumab in the Therapeutic Strategy in Advanced Renal Cell Carcinoma
Keywords: Antiangiogenic; Bevacizumab; Metastatic renal cell carcinoma; Targeted therapy; Therapeutic strategy
Antiproliferative and antiangiogenic effects of flavone eupatorin, an active constituent of chloroform extract of Orthosiphon stamineus leaves
Keywords: AIF; apoptosis inducing factor; CDK; cyclin-dependent kinase; EGFR; epidermal growth factor receptor; HUVEC; human umbilical vein endothelial cells; PARP; poly(ADP-ribose)polymerase; PDGFR; platelet derived growth factor receptor; pH3Ser10; phosphorylated
Agudeza visual a largo plazo en pacientes con degeneración macular asociada a la edad tratados con ranibizumab y persistencia de fluido subretiniano
Keywords: Degeneración macular asociada a la edad; Ranibizumab; Lucentis; Antiangiogénicos; NeovascularizaciónAge-related macular degeneration; Ranibizumab; Lucentis; Antiangiogenic; Neovascularisation
Long-term visual acuity in patients with age-related macular degeneration and persistence of subretinal fluid after treatment with ranibizumab
Keywords: Age-related macular degeneration; Ranibizumab; Lucentis; Antiangiogenic; NeovascularisationDegeneración macular asociada a la edad; Ranibizumab; Lucentis; Antiangiogénicos; Neovascularización
New treatment strategies in advanced neuroendocrine tumours
Keywords: Antiangiogenic; Chemotherapy; Hepatic embolization; Somatostatin; Targeted therapy
The Role of Avastin in the Management of Recurrent Glioblastoma
Keywords: Recurrent glioblastoma; Treatment malignant glioma; Angiogenesis; Angiogenic switch; VEGF; Antiangiogenic; Bevacizumab; Avastin; Radiation necrosis;
Hypertension in Pregnancy
Keywords: Pregnancy; Hypertension; Gestational; Preeclampsia; Eclampsia; Placenta; Angiogenic; Antiangiogenic;
Place des anti-angiogéniques dans le traitement des gliomes
Keywords: Glioblastome; Traitement; Antiangiogéniques; Angiogénèse; Glioblastoma; Treatment; Antiangiogenic; Angiogenesis;
Cancer du rein métastatique : évolution à l'arrêt du traitement antiangiogénique chez des patients en réponse complète, à propos de cinq cas
Keywords: cancer du rein métastatique; antiangiogénique; réponse complète; metastatic renal cancer; antiangiogenic; complete response;
Chimiothérapie métronomique en 2011 : actualités et perspectives
Keywords: chimiothérapie; métronomique; anti-angiogénique; chemotherapy; metronomic; antiangiogenic;
Complementary information from magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model
Keywords: Hypoxia; PET; Antiangiogenic; MRI; Glioma; [18F]-FMISO
Traitements antiangiogéniques en oncologie thoracique : succès, échecs et perspectives
Keywords: Traitement antioangiogénique; Carcinome bronchique non à petites cellules; Carcinome bronchique à petites cellules; Mésothéliome; Bévacizumab; Inhibiteurs de tyrosine-kinases du VEGFR; Antiangiogenic; Small cell lung cancer; Bevacizumab; Non small c
Angiogenic Blockade and Radiotherapy in Hepatocellular Carcinoma
Keywords: Radiotherapy; Hepatocellular carcinoma; Antiangiogenic; Tomotherapy; Sunitinib;
In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues
Keywords: Chalcones; Antiproliferative; Antiangiogenic
Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in rats
Keywords: Antiangiogenic; Hypertension; Side effect; Troponin; Heart
Synthesis of 2- and 17-substituted estrone analogs and their antiproliferative structure–activity relationships compared to 2-methoxyestradiol
Keywords: 2-Methoxyestradiol analogs; Antiproliferative; Antiangiogenic; Structure–activity relationships